✦ LIBER ✦

Differential effects of estrogen treatment on bone mineral density of the spine, hip, wrist and total body in late postmenopausal women

✍ Scribed by W. M. Kohrt; S. J. Birge

Publisher: Springer-Verlag
Year: 1995
Tongue: English
Weight: 577 KB
Volume: 5
Category: Article
ISSN: 0937-941X
DOI: 10.1007/bf02106093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of body weight on rates of cha

Influence of body weight on rates of change in bone density of the spine, hip, and radius in postmenopausal women

✍ Susan Harris; Gerard E. Dallal; Bess Dawson-Hughes 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 660 KB

Interrelationships between percent of ideal body weight (%IBW), serum estrogen levels, and change in bone mineral density (delta BMD) and bone mineral content (delta BMC) were studied in 288 postmenopausal women aged 41-71 years who participated in a 2-year calcium supplement trial. The spine (L2-L4

Effects of alendronate and risedronate o

Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis

✍ Aysegul Atmaca; Olcay Gedik 📂 Article 📅 2006 🏛 Springer Healthcare Communications 🌐 English ⚖ 279 KB

Odanacatib in the treatment of postmenop

Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect

✍ John A Eisman; Henry G Bone; David J Hosking; Michael R McClung; Ian R Reid; Ren 📂 Article 📅 2011 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 211 KB 👁 2 views

## Abstract The selective cathepsin K inhibitor odanacatib (ODN) progressively increased bone mineral density (BMD) and decreased bone‐resorption markers during 2 years of treatment in postmenopausal women with low BMD. A 1‐year extension study further assessed ODN efficacy and safety and the effec

Effects of 1 year of daily teriparatide

Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate

✍ Barbara M Misof; Eleftherios P Paschalis; Stéphane Blouin; Nadja Fratzl-Zelman; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 163 KB 👁 1 views

## Abstract Anabolic treatment with teriparatide of postmenopausal osteoporotic patients previously treated with bisphosphonates is a new therapeutic approach. However, its effects on the bone mineralization density distribution (BMDD) are unknown. We studied paired transiliac bone biopsy samples t

The effects of whole-body vibration trai

The effects of whole-body vibration training and vitamin D supplementation on muscle strength, muscle mass, and bone density in institutionalized elderly women: A 6-month randomized, controlled trial

✍ Sabine MP Verschueren; An Bogaerts; Christophe Delecluse; Albrecht L Claessens; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 189 KB 👁 2 views

Sarcopenia and osteoporosis represent a growing public health problem. We studied the potential benefit of whole-body vibration (WBV) training given a conventional or a high dose of daily vitamin D supplementation in improving strength, muscle mass, and bone density in postmenopausal women. In a 2 ×